show episodes
 
MedEdTalks Hematology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. The intended audience for this series is hematologists, hematology nurses (RNs) and nurse practitioners (NPs), oncology RNs, oncology NPs, hemophilia treatment center RNs, hemophilia treatment center NPs, and other health care professionals.
 
MedEdTalks Rheumatology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on rheumatology topics, such as GCA, ANCA-Associated Vasculitis, Pemphigus Vulgaris, Lupus, Biosimilars, RA, axSpA, irAEs and PSA and includes interviews with Dr. Leonard Calabrese, Dr. Grace Wright, Dr. Jeff Kaine, Dr. John Tesser, Dr. Adam Brown, Dr. John Stone and Dr. Ronald Harris
 
MedEdTalks Neurology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on multiple sclerosis and includes interviews with Dr. Patricia Coyle from Stony Brook Medical Center, Dr. Claire Riley from Columbia University, Dr. Clyde Markowitz from University of Pennsylvania and Dr. Bruce Cohen from Northwestern University.
 
MedEdTalks Cardiology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on cardiovascular risk reduction in patients with diabetes, coordinating efforts between cardiologists and endocrinologists and includes interviews with Dr. Deepak Bhatt and Dr. Peter Toth.
 
MedEdTalks Oncology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on different oncology topics, starting with PTCL. In the first season, we will be talking with Dr. Owen O'Connor from Columbia University in New York City, Dr. Tim Illidge from University of Manchester in the United Kingdom and Dr. Lorenz Trumper from Göttingen University in Germany.
 
MedEdTalks Gastroenterology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on gastroenterology topics, such as ulcerative colitis (UC) and Crohn’s disease and includes interviews with Dr. Peter Higgins from the University of Michigan, Dr. David Rubin from the University of Chicago and Dr. William Sandborn from the University of California, San Diego.
 
MedEdTalks Ophthalmology is a continuing medical education podcast for physicians to allow them to learn while on the go and obtain CME credits. This show will focus in on ophthalmology topics, such as nAMD and Diabetic Retinopathy and includes interviews with Dr. Rishi Singh from the Cole Eye Institute, Dr. Andrew Moshfeghi from the USC Roski Eye Institute, Dr. Dilsher Dhoot from California Retina Consultants, Dr. Theodore Leng from Byers Eye Institute at Stanford, Dr. Nathan Steinle from C ...
 
Loading …
show series
 
Hemophilia A is an X-linked recessive disease primarily affecting males. An estimated 20,000 individuals in the United States have the disease. Conventional standard of care for patients with severe disease is factor VIII administration given prophylactically or to treat bleeding episodes. Almost 30% of patients treated with factor VIII develop neu…
 
In this podcast, expert clinicians will discuss treatment for a patient with refractory Mycobacterium avium complex lung disease despite many months of guidelines-based therapy. For CME Credit, complete activity here: https://tinyurl.com/LungMET2By Anne O'Donnell MD
 
In this podcast, expert clinicians will discuss treatment for Mycobacterium avium complex lung infection in a patient with underlying granulomatosis with polyangiitis affecting the lungs. For CME Credit, complete activity here: https://tinyurl.com/LungMET1By Anne O'Donnell MD
 
In this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Len Calabrese and Cassandra Calabrese review zoster vaccine side effec…
 
In this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Calabrese and Sax review zoster vaccine safety and efficacy and discus…
 
In this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Calabrese and Curtis discuss primary risk factors for HZ, incidence ra…
 
In this 4-part CME podcast series, experts will review the clinical aspects and primary risk factors for HZ, discuss optimized use of vaccines for at-risk populations, and provide guidance on effective patient education strategies to enhance vaccine uptake. In this episode, Drs. Len Calabrese and Cassandra Calabrese discuss the clinical manifestati…
 
In this podcast, expert clinicians will discuss multidisciplinary care approaches to consider in tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychoti…
 
In this podcast, expert clinicians will discuss available therapies for tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with…
 
In this podcast, expert clinicians will discuss the burden of tardive dyskinesia (TD) on the patient and health care system. TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsych…
 
In this podcast, expert clinicians will discuss the symptoms, pathology, and causes of tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is …
 
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention (CDC) estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths …
 
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention (CDC) estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths …
 
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention (CDC) estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths …
 
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment regimens have provided significant improvements to long-term visual outcomes in neovascular age-related macular degeneration (nAMD). However, some patients do not receive an optimal response with current anti-VEGF therapies, while poor adherence due to treatment burden remai…
 
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment regimens have provided significant improvements to long-term visual outcomes in neovascular age-related macular degeneration (nAMD). However, some patients do not receive an optimal response with current anti-VEGF therapies, while poor adherence due to treatment burden remai…
 
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment regimens have provided significant improvements to long-term visual outcomes in neovascular age-related macular degeneration (nAMD). However, some patients do not receive an optimal response with current anti-VEGF therapies, while poor adherence due to treatment burden remai…
 
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment regimens have provided significant improvements to long-term visual outcomes in neovascular age-related macular degeneration (nAMD). However, some patients do not receive an optimal response with current anti-VEGF therapies, while poor adherence due to treatment burden remai…
 
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment regimens have provided significant improvements to long-term visual outcomes in neovascular age-related macular degeneration (nAMD). However, some patients do not receive an optimal response with current anti-VEGF therapies, while poor adherence due to treatment burden remai…
 
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths a…
 
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths a…
 
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths a…
 
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths a…
 
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths a…
 
While the impact of influenza varies, it places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths a…
 
The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patie…
 
The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patie…
 
The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patie…
 
The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patie…
 
The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patie…
 
The integration of intravitreal anti-vascular endothelial growth factor therapies into treatment algorithms for the management of neovascular retinal diseases has provided significant visual outcome gains for these patients. The effectiveness of current treatment algorithms varies based on treatment protocol, number of therapy injections, and patie…
 
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the s…
 
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the s…
 
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the s…
 
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the s…
 
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Inflammation associated with EGPA can lead to injury in multiple organ systems, including the s…
 
In this case-based podcast, Leonard H. Calabrese, DO, and Ann P. Murchison, MD, MPH, discuss issues related to the workup, diagnosis, and treatment of a patient with new-onset visual symptoms presenting to the emergency department.By Leonard Calabrese, DO
 
Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. Despite new treatment options for patients with GCA, delays in diagnosis and treatment lead to poor outcomes, such as the increased risk for visual impairments and incidence of heart attacks, transient ischemic attacks, and/or mortality. Diagnosis of GCA rema…
 
In this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss blood pressure control as well as optimizing care coordination and medication management in the patient with diabetes. Transcript: https://tinyurl.com/yj8zwh69 To earn CME credit, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-…
 
In this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss the latest data on reducing CV risk in patients with diabetes. Transcript: https://tinyurl.com/yeendrms To earn CME Credit, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-reducing-cv-risk-in-patients-with-diabetes-a-discussion-…
 
Loading …

Quick Reference Guide

Copyright 2020 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login